Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Dec 10, 2009

Premium

Bio-Rad director Ruediger Naumann-Etienne has resigned from the company’s board effective Dec. 4, the firm said this week in a filing with the US Securities and Exchange Commission.

Naumann-Etienne was an independent director and a member of the board's audit and compensation committees. Bio-Rad noted in its SEC filing that his departure "is not related to any disagreement with the company’s operations, policies, or practices."

However, as a result of Naumann-Etienne's resignation, Bio-Rad no longer complies with the New York Stock Exchange's audit committee guidelines, which require three directors.

Bio-Rad said that it notified NYSE on Dec. 9 that it is not in compliance with this requirement. It added that it is seeking a replacement for Naumann-Etienne and intends to regain compliance with NYSE requirements "as soon as practicable."

Filed under

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.